Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
MP Materials
MP
$11.2B
| $4.86M | ﹤0.01% |
172,400
-20,500
| -11% | -$578K |
|
|
HCP
1302
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $4.86M | ﹤0.01% |
+165,900
| New | +$4.86M |
|
|
JOYY
1303
JOYY Inc. American Depositary Shares
JOYY
$3.21B
| $4.85M | ﹤0.01% |
155,508
+35,700
| +30% | +$1.11M |
|
|
SAGE
1304
DELISTED
Sage Therapeutics
SAGE
| $4.85M | ﹤0.01% |
115,500
-13,700
| -11% | -$575K |
|
1305
National Health Investors
NHI
$3.72B
| $4.83M | ﹤0.01% |
93,620
-14,200
| -13% | -$732K |
|
|
GRP.U
1306
Granite Real Estate Investment Trust
GRP.U
$3.43B
| $4.81M | ﹤0.01% |
77,800
| – | – |
|
1307
Freshworks
FRSH
$3.63B
| $4.81M | ﹤0.01% |
313,000
-2,900
| -0.9% | -$44.5K |
|
1308
Simmons First National
SFNC
$2.96B
| $4.79M | ﹤0.01% |
274,086
-35,700
| -12% | -$624K |
|
|
MDC
1309
DELISTED
M.D.C. Holdings, Inc.
MDC
| $4.78M | ﹤0.01% |
123,043
-14,500
| -11% | -$564K |
|
|
GMS
1310
DELISTED
GMS Inc
GMS
| $4.77M | ﹤0.01% |
82,400
-9,500
| -10% | -$550K |
|
1311
Frontline
FRO
$5.17B
| $4.77M | ﹤0.01% |
291,053
-33,201
| -10% | -$544K |
|
1312
Privia Health
PRVA
$2.8B
| $4.77M | ﹤0.01% |
172,600
-15,600
| -8% | -$431K |
|
1313
Affirm
AFRM
$27.1B
| $4.76M | ﹤0.01% |
422,200
-368,775
| -47% | -$4.16M |
|
1314
Denali Therapeutics
DNLI
$2.07B
| $4.73M | ﹤0.01% |
205,200
-3,300
| -2% | -$76K |
|
1315
QuantumScape
QS
$5.63B
| $4.72M | ﹤0.01% |
577,000
-56,300
| -9% | -$461K |
|
|
RCM
1316
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.72M | ﹤0.01% |
314,600
-37,000
| -11% | -$555K |
|
1317
AeroVironment
AVAV
$12.1B
| $4.69M | ﹤0.01% |
51,200
-6,100
| -11% | -$559K |
|
1318
Mueller Water Products
MWA
$3.91B
| $4.69M | ﹤0.01% |
336,400
-41,900
| -11% | -$584K |
|
1319
Artisan Partners
APAM
$3.27B
| $4.69M | ﹤0.01% |
146,600
-16,200
| -10% | -$518K |
|
1320
Navient
NAVI
$1.28B
| $4.68M | ﹤0.01% |
292,700
-49,800
| -15% | -$796K |
|
1321
Douglas Emmett
DEI
$2.79B
| $4.68M | ﹤0.01% |
379,400
-45,100
| -11% | -$556K |
|
1322
Carpenter Technology
CRS
$12B
| $4.68M | ﹤0.01% |
104,500
-12,100
| -10% | -$542K |
|
1323
InterDigital
IDCC
$8.33B
| $4.67M | ﹤0.01% |
64,000
-7,600
| -11% | -$554K |
|
|
AXNX
1324
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.66M | ﹤0.01% |
85,500
-8,900
| -9% | -$486K |
|
|
NUVA
1325
DELISTED
NuVasive, Inc.
NUVA
| $4.65M | ﹤0.01% |
112,569
-13,200
| -10% | -$545K |
|